Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Clinical trial NCT05687721 · WITHDRAWN

Trial details

NCT number: NCT05687721
Sponsor: VA Office of Research and Development
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Urothelial Carcinoma

Start date: 2025-06-02
Primary completion: 2025-06-02
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.